CME/CE - PACE-CME

Episodes 49-64 of 139

CETP inhibition: Lessons from two decades of clinical trials
CETP inhibition: Lessons from two decades of clinical trials
MinuteCE®
CETP inhibition: Lessons from two decades of clinical trials
0.50 program credits
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
0.50 program credits
Understanding the role of triglycerides in the assessment of residual risk
Understanding the role of triglycerides in the assessment of residual risk
MinuteCE®
Understanding the role of triglycerides in the assessment of residual risk
0.50 program credits
- Prof. Alberto Zambon MD, PhD, FAHA
0.50 program credits
Integrating EPA in CV risk reduction strategies: Practical experience and guidance
Integrating EPA in CV risk reduction strategies: Practical experience and guidance
MinuteCE®
Integrating EPA in CV risk reduction strategies: Practical experience and guidance
0.50 program credits
- Azfar Zaman, MD
0.50 program credits
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
MinuteCE®
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
0.50 program credits
- Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
0.50 program credits
MinuteCE®
Innovating the clinical management of LDL-c: Exploring CETP as therapeutic target
0.50 credits 3 episodes
- Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
- Erin Michos
0.50 credits 3 episodes
MinuteCE®
Clinical scenarios addressing residual risk in ASCVD: Understanding the role of triglycerides and EPA
0.50 credits 3 episodes
- Prof. Alberto Zambon MD, PhD, FAHA
- Kausik Ray, MBChB, MD, MPhil
- Azfar Zaman, MD
0.50 credits 3 episodes
Managing a patient with residual risk: Applying recent evidence with EPA to practice
Managing a patient with residual risk: Applying recent evidence with EPA to practice
MinuteCE®
Managing a patient with residual risk: Applying recent evidence with EPA to practice
0.50 program credits
- Prof. Kausik Ray
0.50 program credits
The clinical challenge of managing a patient with HCM
The clinical challenge of managing a patient with HCM
MinuteCE®
The clinical challenge of managing a patient with HCM
0.75 program credits
- Iacopo Olivotto, MD
0.75 program credits
Updates From the 7th World Symposium Task Force
Updates From the 7th World Symposium Task Force
CME/CE
Updates From the 7th World Symposium Task Force
1.00 credit
- Eric D. Austin, MD, MSCI
- Hilary M. DuBrock, MD
- H. James Ford, MD
- Gustavo A. Heresi, MD, MS
- Gergely Meszaros, JD, MSc
- Oksana A. Shlobin, MD
- Ioana Preston, MD
- Lucilla Piccari, MD, PhD
1.00 credit
MinuteCE®
Managing hypertrophic cardiomyopathy in clinical practice: The patient journey
0.75 credits 3 episodes
- Perry Elliott, MD
- Roberto Barriales-Villa, MD, PhD
- Iacopo Olivotto, MD
0.75 credits 3 episodes
Understanding the etiology of HCM and pathways for intervention
Understanding the etiology of HCM and pathways for intervention
MinuteCE®
Understanding the etiology of HCM and pathways for intervention
0.75 program credits
- Roberto Barriales-Villa, MD, PhD
0.75 program credits
What are the challenges in making the right diagnosis in HCM?
What are the challenges in making the right diagnosis in HCM?
MinuteCE®
What are the challenges in making the right diagnosis in HCM?
0.75 program credits
- Perry Elliott, MD
0.75 program credits
MinuteCE®
Optimizing Care for Patients with CKM Syndrome: A Multidisciplinary Approach
1.00 credit 4 episodes
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
- Jürgen Floege, PhD
- Muthiah Vaduganathan, MD, MPH
1.00 credit 4 episodes
Screening for CKM Syndrome
Screening for CKM Syndrome
MinuteCE®
Screening for CKM Syndrome
1.00 program credit
- Jürgen Floege, PhD
1.00 program credit
Comprehensive Management of Individuals with CKM Syndrome
Comprehensive Management of Individuals with CKM Syndrome
MinuteCE®
Comprehensive Management of Individuals with CKM Syndrome
1.00 program credit
- Muthiah Vaduganathan, MD
1.00 program credit
Definition and Staging of CKM Syndrome
Definition and Staging of CKM Syndrome
MinuteCE®
Definition and Staging of CKM Syndrome
1.00 program credit
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
1.00 program credit

4/9